Your browser doesn't support javascript.
loading
Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation.
Shibata, Sho; Arai, Yasuyuki; Kondo, Tadakazu; Mizuno, Shohei; Harada, Kaito; Miyakoshi, Shigesaburo; Uchida, Naoyuki; Maruyama, Yumiko; Eto, Tetsuya; Katsuoka, Yuna; Matsue, Kosei; Nishiwaki, Kaichi; Takada, Satoru; Doki, Noriko; Itoh, Mitsuru; Nagafuji, Koji; Kawakita, Toshiro; Tanaka, Junji; Fukuda, Takahiro; Atsuta, Yoshiko; Yanada, Masamitsu.
Afiliación
  • Shibata S; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Arai Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for Research and Application of Cellular Therapy, Kyoto University Hospital, Kyoto, Japan. Electronic address: ysykrai@kuhp.kyoto-u.ac.jp.
  • Kondo T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
  • Harada K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Miyakoshi S; Department of Hematology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
  • Maruyama Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Katsuoka Y; Department of Hematology, National Hospital Organization Sendai Medical Center, Sendai, Japan.
  • Matsue K; Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Nishiwaki K; Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan.
  • Takada S; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Itoh M; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
  • Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume, Japan.
  • Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Transplant Cell Ther ; 29(5): 332.e1-332.e11, 2023 05.
Article en En | MEDLINE | ID: mdl-36796517
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article País de afiliación: Japón